| Literature DB >> 35655226 |
Andreas Ateke Njoh1,2, Yauba Saidu3,4, Hassan Ben Bachir5, Shalom Tchokfe Ndoula6, Eric Mboke6, Raoul Nembot6, Afizu Chrakoh Tambasho6, Messang Blandine Abizou7, Judith Seungue6, Clarence Mbanga7, Victor Njie Mbome8.
Abstract
INTRODUCTION: Cameroon's Southwest Region (SW) has been hit by an armed conflict for over half a decade now, negatively affecting the region's routine immunization and disease surveillance activities. This negative effect was further acerbated by the COVID-19 pandemic, which alongside the conflict, caused thousands of children to miss out on life-saving vaccinations. Herein, we present the contribution of periodic intensification of routine immunization in improving immunization and surveillance activities amid crises.Entities:
Keywords: Armed conflict; COVID-19; Cameroon; Periodic intensification of routine immunization; South west region
Year: 2022 PMID: 35655226 PMCID: PMC9161648 DOI: 10.1186/s13031-022-00461-1
Source DB: PubMed Journal: Confl Health ISSN: 1752-1505 Impact factor: 4.554
Fig. 1EPI Immunization schedule in Cameroon. This figure illustrates the vaccination calendar of Cameroon. The timeframe under each vaccine indicates the age from birth at which the vaccine is authorized to be administered to the target. For pregnant women who received the tetanus vaccine in childhood, three doses of Td are administered. The first dose at contact and the next is given one month after, and the third dose is given six months after the third dose. For women who did not receive a tetanus vaccine in childhood, a total of five doses are administered. After the first three doses above, a fourth dose is given 1 year later and the fifth dose 1 year after the fourth. BCG: Bacilli, Calmette Guerin, bOPV: bivalent Oral Polio Vaccine, DPT-HepB-Hib: Diphtheria, Pertussis, Tetanus Hepatitis B and Hemophilus influenza B, HPV: Human Papilloma Virus, IPV: Inactivated Polio Vaccine, MR: Measles and Rubella, PCV: Pneumococcal Conjugate Vaccine, SARS COV 2: Severe Acute Respiratory Syndrome Corona Virus two, Td: Tetanus Dyphteriam, YF: Yellow Fever
Fig. 2Trends in the number of infants vaccinated and reported in Dhis 2 in 2020. The line graph presents the trend in the total number of infants or adolescents vaccinated with the third dose of DPT (Penta), first and second dose of Measles-Rubella vaccine, and the first dose of Human Papilloma Virus Vaccine (for adolescent girls). The blue line represents the infants vaccinated with DPT-3 (Penta 3). The brown represents those immunized with the first dose of the Measles-Rubella vaccine. Meanwhile, the black line represents the infants vaccinated with the second dose of the Measles-Rubella vaccine. Finally, the yellow line represents the infants vaccinated with the first dose of the Human Papilloma Virus vaccine (introduced 12 October 2020). The spikes represent the periods of PIRI, while the lull represents the period of routine immunization
Fig. 3Trend in the investigation of Acute Flaccid Paralysis (AFP) per health district of the Southwest Regions from 2019–2020. A schematic representation of the evolution of AFP investigation in the southwest region of Cameroon between 2019 and 2020. For the corresponding periods, the areas in green are health districts that investigated at least a case of AFP during the given year. Meanwhile, the areas in red are health districts that did not investigate even a case of AFP for the corresponding period
Fig. 4DPT-3 coverage per district 2019 to 2020. The bar chart presents the DPT-3 coverage for the respective health districts of the SW. Blue represents the coverage in 2019 while brown presents the coverage in 2020
Trend in immunization equity in the region over 5 years
| South west region | |||||
|---|---|---|---|---|---|
| 2016 | 2017 | 2018 | 2019 | 2020 | |
| District with VC < 20%, n (%) | 0 (0) | 0 (0) | 2 (11) | 1 (5) | 1 (5) |
| District with 20% < = VC < 40%, n (%) | 2 (68) | 2 (11) | 5 (28) | 13 (68) | 2 (11) |
| District with 40% < = VC < 60%, n (%) | 7 (16) | 1(6) | 6 (33) | 3 (16) | 5 (28) |
| District with 60% < = VC < 80%, n (%) | 9 (11) | 5 (28) | 1 (6) | 2 (11) | 3 (16) |
| Districts with VC > = 80%, n (%) | 1 (5) | 12(67) | 4 (22) | 0 (0) | 7 (39) |
| District with VC < 20%, n (%) | 0 (0) | 0 (0) | 2 (11) | 3 (16) | 2 (11) |
| District with 20% < = VC < 40%, n (%) | 0 (0) | 1 (6) | 5 (28) | 9 (47) | 2 (11) |
| District with 40% < = VC < 60%, n (%) | 3 (16) | 1 (6) | 6 (33) | 3 (16) | 4 (21) |
| District with 60% < = VC < 80%, n (%) | 13 (68) | 2 (11) | 1 (6) | 4 (21) | 2 (11) |
| Districts with VC > = 80%, n (%) | 3 (16) | 14(78) | 4 (22) | 0 (0) | 6 (33) |
| District with VC < 20%, n (%) | 0 (0) | 0 (0) | 2 (11) | 2 (11) | 1 (6) |
| District with 20% < = VC < 40%, n (%) | 0 (0) | 2 (11) | 6 (33) | 10 (53) | 4 (22) |
| District with 40% < = VC < 60%, n (%) | 5 (26) | 0 (0) | 4 (22) | 4 (21) | 4 (21) |
| District with 60% < = VC < 80%, n (%) | 11 (58) | 3 (17) | 2 (11) | 3 (16) | 3 (17) |
| Districts with VC > = 80%, n (%) | 3 (16) | 13 (72) | 4 (22) | 0 (0) | 6 (33) |
BCG bacilli, calmette guerin, DPT-HepB-Hib diphtheria, pertussis, tetanus Hepatitis B and hemophilus influenza B, MR measles and rubella, VC vaccination coverage
Presents the evolution in the vaccination coverage in all the health districts of the southwest per year from 2016 to 2020 for DPT-3, BCG, and MR. The absolute numbers (n) indicate the number of districts whose coverage fall within the respective coverage ranges for each of the vaccines. In brackets are the percentages obtained from the denominator of 18 health districts in the SW in 2020